Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Combination with Dexamethasone in DME
NCT05271539Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in diabetic macular edema (DME) (2 arms), sponsored by Cairo University. Primary endpoints: Central Foveal Thickness at 6 months, Best Corrected Visual Acuity at 6 months and 1 more. Started Jul 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05271539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05271539.